Commentary on management of osteoporosis in advanced CKD - common view of a nephrologist and a bone specialist
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F19%3AN0000175" target="_blank" >RIV/00064173:_____/19:N0000175 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.4158/EP-2018-0311" target="_blank" >https://doi.org/10.4158/EP-2018-0311</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Commentary on management of osteoporosis in advanced CKD - common view of a nephrologist and a bone specialist
Original language description
The manuscript summarizes current consensual view of bone specialists and a nephrologist of the management of osteoporosis in patients with advanced chronic kidney disease (CKD) as a part of CKD-MBD (mineral and bone disorder associated with CKD). Osteoporosis has been recently accepted as a subunit of CKD-MBD, occurring in up to one third of advanced CKD patients, with fractures being the most severe complication. Diagnosis and differential diagnosis is currently based on non-invasive procedures (densitometry, laboratory assessment of calcium-phosphate metabolism and bone turnover); originally recommended bone biopsy is reserved for unclear cases. Specific treatment is complicated since majority of anti-osteoporotic drugs are contraindicated in advanced CKD and all of them lack robust data on effectiveness and safety in this specific population.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů